NCT01029990

Brief Summary

Women who don't participate in Swedish cytology screening program are a minority of about 10%, but constitute the majority of those who acquire cervical cancer. Over 50 000 women in the Västra Götalandregion have abstained from participation in the program for at least 2 screening rounds (6 - 10 years, depending om age). We plan to test two promising strategies to increase participation. In a study of two different health policies women who have defaulted are randomised to receiving a telephone call from a midwife, receive an offer of a self-test for HPV or being included in a control group. This is an effectiveness study that should give an answer how participation could be increased and give the basis for a calculation of the costs involved, before decisions can be made about implementing either intervention.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,800

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Sep 2009

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 10, 2009

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
Last Updated

August 30, 2012

Status Verified

August 1, 2012

Enrollment Period

5 months

First QC Date

December 9, 2009

Last Update Submit

August 29, 2012

Conditions

Keywords

participationmass screeningcervical neoplasiahealth economicscost-benefit

Outcome Measures

Primary Outcomes (2)

  • Frequency of testing (cytology in arm A and C and HPV-test in arm B). F

    7 months after invitation

  • Frequency of further assessment of abnormal tests

    7 months

Secondary Outcomes (5)

  • Frequency of abnormal smears. (Arm A vs arm C)

    7 months

  • Frequency of treated CIN (Arm A vs. arm C)

    7 months

  • Number of invasive cancers detected classified by FIGO stadium.

    7 months

  • Cost of interventions

    7 months

  • Cost per CIN2+ found and treated

    7 months

Study Arms (3)

Telephone arm

EXPERIMENTAL

A midwife tries to contact the woman by telephone and offer her an appointment for a PAP-smear

Other: Telephone arm

Self-test arm

EXPERIMENTAL
Other: Self-test arm

Control arm

NO INTERVENTION

No intervention other than what is routine in the screening program

Interventions

Midwifes at 72 antenatal care units in West region of Sweden receive lists with names and telephone numbers on women who have no record of screening during two screening rounds (6 - 10 years depending on age). The midwife will make up to ten attempts to reach each woman and is instructed to use no more than 30 minutes on this. If the midwife get in touch with the woman she will encourage participation in regular screening (run by midwives in Sweden) and help the woman to get an appointment.

Telephone arm

Women receive an offer to order a vaginal self test for HPV. The woman can return a coupon in a postage free envelope and she will receive a self testing kit (dry method) within a couple of days. She will return the test in another postage free envelope. A reminder will be sent to women who order a test but do not return it.

Self-test arm

Eligibility Criteria

Age29 Years - 63 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • No record of PAP smear in the regional screening register for more than two screening rounds (6 - 10 years depending on age).
  • Evidence in the regional population register that women have been living in the west region of Sweden during this time.

You may not qualify if:

  • Total hysterectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Uterine Cervical Dysplasia

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Björn Strander, MD, PhD

    Göteborg University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
CARE PROVIDER
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2009

First Posted

December 10, 2009

Study Start

September 1, 2009

Primary Completion

February 1, 2010

Study Completion

January 1, 2011

Last Updated

August 30, 2012

Record last verified: 2012-08